Oracle Argus Safety processes 10 million adverse event cases annually for pharmaceutical companies worldwide, according to Oracle. Yet module-specific issues continue to delay regulatory submissions, ...

Opening up about drug pricing decisions is not optional for biopharma anymore. For the sake of credibility, companies should embrace it.

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. The data come from 20 pharmas that had the highest R&D budgets in 2020, as ...

SCOTTSDALE, Ariz., Oct. 29, 2025 /PRNewswire/ -- CustomerInsights.AI (CIAI) today announced the launch of ciATHENA's Market Mix Modeling (MMM) use case: the pharma industry's first Agentic AI-powered ...